GE HealthCare Technologies Inc. Common Stock vs SSR Mining Inc. Common Stock — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while SSR Mining Inc. Common Stock trades at $31 (market cap $6.72B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 4.6× SSR Mining Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays the higher dividend (0.23%). Which is the better fit depends on your goals.
| GEHC | SSRM | |
|---|---|---|
Market Cap | $31.07B | $6.72B |
Volume | 3,443,020 | 3,758,896 |
Sector | Health | Basic Materials |
52-Week High | $88.16 | $39.21 |
52-Week Low | $59.48 | $19.48 |
Enterprise Value | $39.53B | $4.89B |
Dividend Yield | 0.23% | 0.09% |
Typical Hold Time | — | 1 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SSR Mining (SSRM) trades at $33.09, down 6.63% amid recent volatility, yet maintains strong fundamentals with a P/E of 12.44 and net income margin of 12.3%. The company recently announced the $464 million acquisition of Roxmore Resources, which could add 170,000 ounces of annual gold production. Technical indicators show a bullish trend with support at $34-$35, while earnings have beaten expectations in two of the last three quarters.
The outlook remains positive with a consensus price target of $42.67 (29% upside), driven by strategic acquisitions and Americas-focused growth. Risks include execution of the Roxmore integration and gold price sensitivity. Analysts are bullish (73% buy ratings), citing the company's debt-free balance sheet and $1.8 billion cash position.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →SSR Mining operates precious-metals mines in the United States, Canada, and Argentina. It produces gold doré and concentrates containing copper, silver, lead, and zinc.
Read more on SSRM →